News

Generic drug companies rework pricing to gain weight in Indias GLP-1 market as Novo Nordisk slashes Wegovy prices

Indian drugmakers are adjusting prices for weight-loss injections. Novo Nordisk has cut prices for its drug Wegovy. This move is prompting generic companies to lower their expected launch prices. Novo Nordisk is also preparing to launch Ozempic in India soon. This competition is expected to drive down prices in the GLP-1 segment.